PMID: 11604572Oct 18, 2001Paper

Trends in transplantation of hematopoietic stem cells from unrelated donors

Current Opinion in Hematology
C AnasettiJ A Hansen

Abstract

Transplants of hematopoietic stem cells from unrelated donors have become feasible for patients with a growing variety of hematologic disorders. The probability of finding a suitable donor has increased because of the expansion of the network of registries containing more than seven million HLA-typed donors worldwide. The selection of compatible donors has become more effective, thanks to the discovery of new HLA alleles and the development of precise and efficient HLA typing methods using DNA technology. Improved methods for transplantation may provide the opportunity to further decrease treatment-related toxicity and improve survival.

References

Dec 27, 1990·The New England Journal of Medicine·K FleischhauerS Y Yang
Dec 24, 1996·Proceedings of the National Academy of Sciences of the United States of America·E W PetersdorfJ A Hansen
Apr 2, 1998·The New England Journal of Medicine·J A HansenC Anasetti
Sep 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S J LeeJ H Antin
Aug 28, 1999·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·H J DeegC Howe
Aug 10, 2000·British Journal of Haematology·D Y ZangF Appelbaum
Apr 5, 2001·The New England Journal of Medicine·B J DrukerC L Sawyers
Apr 12, 2001·British Journal of Haematology·E W PetersdorfJ A Hansen
Apr 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R P WitherspoonF R Appelbaum
May 15, 2001·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·H J DeegB Mueller

❮ Previous
Next ❯

Citations

Oct 6, 2007·Immunologic Research·Chaim M RoifmanLuigi Notarangelo
Feb 12, 2008·Bone Marrow Transplantation·C M RoifmanE Grunebaum
Jan 6, 2006·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Alex VeldmanWerner Rettwitz Volk
Mar 22, 2003·American Journal of Respiratory and Critical Care Medicine·Jason W ChienJoan G Clark
Aug 7, 2008·Drugs·Gordon MallarkeyMadlen Gazarian
Jun 6, 2003·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·D C Jones, N T Young
Jan 9, 2003·The Journal of Laboratory and Clinical Medicine·Steven M DevineJohn F DiPersio
May 16, 2003·Bone Marrow Transplantation·S Heimfeld
Feb 26, 2003·Current Opinion in Oncology·Leo LuznikEphraim J Fuchs
Dec 14, 2004·Reproductive Biomedicine Online·R G Edwards

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.